iHuman Inc.
No SEC Form 4 filings for $IH in the last 30 days.
See all $IH insider activity →iHuman Inc (IH) reported a Q2 2026 net loss of RMB 17.53 million ($2.58 million) due to lower revenue and higher expenses, compared to a profit of RMB 30.67 million a year ago. Revenue fell to RMB 173.38 million ($25.55 million) from RMB 210.91 million. Shares traded down 0.87% at $1.1400 on the NYSE.
iHuman Inc. (IH) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 iHuman Inc. Announces Second Quarter 2026 Unaudited Financial Results BEIJING, China, Sep. 29, 2026 -- iHuman Inc. (NYSE: IH) (“iHuman” or the “Company”), a leading provider of tech-powered knowledge and personal growth products, today announced its unaudited financi
iHuman Inc. (NYSE: IH) announced it filed its 2025 annual report on Form 20-F with the U.S. Securities and Exchange Commission on April 24, 2026, for the fiscal year ended December 31, 2025. The report, including audited financial statements, is available on the company's investor relations website. Shareholders and American Depositary Share (ADS) holders can also request a free hard copy by contacting iHuman's Beijing office.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning IH (iHuman Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 2 bearish.
Recent IH coverage spans financial news and earnings.
The loss and higher expenses suggest weaker performance, likely pressuring the stock lower.
The earnings miss and widening losses suggest near‑term downside pressure on the stock.
The filing of the 2025 Form 20-F indicates ongoing compliance and transparency, potentially bolstering investor confidence.
The surge in short interest combined with a bearish analyst consensus indicates increased bearish sentiment, which may lead to further price declines in the near term.
The director's substantial indirect ownership of 144 million Class B shares suggests confidence in the company's prospects, which could be viewed positively by the market.
AlphAI scores every news story that mentions IH with an AI model for sentiment and relevance, and aggregates insider trades from iHuman Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
iHuman Inc (IH) reported a Q2 2026 net loss of RMB 17.53 million ($2.58 million) due to lower revenue and higher expenses, compared to a profit of RMB 30.67 million a year ago. Revenue fell to RMB 173.38 million ($25.55 million) from RMB 210.91 million. Shares traded down 0.87% at $1.1400 on the NYSE.
2 min readiHuman Inc. (IH) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 iHuman Inc. Announces Second Quarter 2026 Unaudited Financial Results BEIJING, China, Sep. 29, 2026 -- iHuman Inc. (NYSE: IH) (“iHuman” or the “Company”), a leading provider of tech-powered knowledge and personal growth products, today announced its unaudited financi
2 min readiHuman Inc. (NYSE: IH) announced it filed its 2025 annual report on Form 20-F with the U.S. Securities and Exchange Commission on April 24, 2026, for the fiscal year ended December 31, 2025. The report, including audited financial statements, is available on the company's investor relations website. Shareholders and American Depositary Share (ADS) holders can also request a free hard copy by contacting iHuman's Beijing office.
2 min readiHuman Inc. Sponsored ADR (NYSE:IH) experienced a significant surge in short interest during March, increasing by 311.4% to 1,876 shares. This comes after a "Sell" rating from Weiss Ratings and an overall "Sell" consensus from analysts, despite a hedge fund, Acadian Asset Management LLC, recently acquiring a new position in the company. The stock exhibited a daily trading volume of 5,346 shares and closed at $1.79 on Wednesday, suggesting a relatively low days-to-cover ratio.
3 min readiHuman Inc. director Chi Yufeng has filed an initial statement of beneficial ownership (Form 3) revealing indirect holdings of 144,000,000 Class B ordinary shares through Academy Management Ltd. This filing is a disclosure of an existing substantial stake rather than a new transaction, indicating no recent purchase or sale by the director. The report specifies the nature of the security as Class B ordinary shares.
2 min read
